Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.17 CAD -8.11%
Market Cap: 6.9m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Gross Margin
Innovotech Inc

68.6%
Current
71%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.6%
=
Gross Profit
843.1k
/
Revenue
1.2m

Gross Margin Across Competitors

Country CA
Market Cap 6.6m CAD
Gross Margin
69%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 200.7B USD
Gross Margin
41%
Country US
Market Cap 172.1B USD
Gross Margin
60%
Country KR
Market Cap 67.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.6B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.9B USD
Gross Margin
35%
Country US
Market Cap 26.9B USD
Gross Margin
59%
Country US
Market Cap 23.4B USD
Gross Margin
35%
Country US
Market Cap 23.2B USD
Gross Margin
60%
No Stocks Found

Innovotech Inc
Glance View

Market Cap
6.6m CAD
Industry
Life Sciences Tools & Services

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.07 CAD
Overvaluation 60%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.6%
=
Gross Profit
843.1k
/
Revenue
1.2m
What is the Gross Margin of Innovotech Inc?

Based on Innovotech Inc's most recent financial statements, the company has Gross Margin of 68.6%.